228
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema

ORCID Icon, , , , , , , , , & show all
Pages 232-239 | Received 18 Jun 2018, Accepted 24 Oct 2018, Published online: 19 Nov 2018

References

  • Awano, N. , et al. , 2017. Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone. Histopathology, 70 (6), 896–905.
  • Buendia-Roldan, I. , et al. , 2016. Increased expression of CC16 in patients with idiopathic pulmonary fibrosis. PLoS One, 11, e0168552.
  • Burdick, M.D. , et al. , 2005. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. American journal of respiratory and critical care medicine, 171 (3), 261–268.
  • Cai, T. , et al. , 2018. IL-17-producing ST2+ group 2 innate lymphoid cells play a role in lung inflammation. Journal of allergy and clinical immunology, pii: S0091-6749(18)30453-6. doi: 10.1016/j.jaci.2018.03.007.
  • Capelli, A. , et al. , 1999. Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics. The european respiratory journal, 14 (1), 160–165.
  • Cottin, V. , 2005. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. European respiratory journal, 26 (4), 586–593.
  • Cottin, V. , 2013. The impact of emphysema in pulmonary fibrosis. European respiratory review: an official journal of the European respiratory society, 22 (128), 153–157.
  • Cottin, V. , and Cordier, J.F. , 2012. Combined pulmonary fibrosis and emphysema in connective tissue disease. Current opinion in pulmonary medicine, 18 (5), 418–427.
  • Cottin, V. , et al. , 2010. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. European respiratory journal, 35 (1), 105–111.
  • Cottin, V. , et al. , 2011. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis and rheumatology, 63 (1), 295–304.
  • De Boer, W.I. , et al. , 2000. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. The journal of pathology, 190 (5), 619–626.
  • Fulkerson, P.C. , et al. , 2006. Persistent effects induced by IL-13 in the lung. American journal of respiratory cell and molecular biology, 35 (3), 337–346.
  • Gioia, S.D. , et al. , 2017. From genesis to revelation: the role of inflammatory mediators in chronic respiratory diseases and their control by nucleic acid-based drugs. Current drug delivery, 14, 253–271.
  • Hanaoka, M. , et al. , 2012. Comparison of gene expression profiling between lung fibrotic and emphysematous tissues sampled from patients with combined pulmonary fibrosis and emphysema. Fibrogenesis and tissue repair, 5 (1), 17.
  • Hoyle, G.W. , et al. , 1999. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. American Journal of pathology, 154 (6), 1763–1775.
  • Jankowich, M.D. , and Rounds, S. , 2010. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung, 188 (5), 365–373.
  • Jankowich, M.D. , and Rounds, S.I. , 2012. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest, 141 (1), 222–231.
  • Jiang, D. , et al. , 2004. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.[see comment]. Journal of clinical investigation, 114 (2), 291–299.
  • Jiang, D. , et al. , 2010. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. The journal of clinical investigation, 120 (6), 2049–2057.
  • Kang, M.-J. , et al. , 2015. Role of chitinase 3-like-1 in interleukin-18-induced pulmonary type 1, type 2, and type 17 inflammation; alveolar destruction; and airway fibrosis in the murine lung. American journal of respiratory cell and molecular biology, 53 (6), 863–871.
  • Lucattelli, M. , et al. , 2005. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respiratory research, 6, 83.
  • Lundblad, L.K. , et al. , 2005. Tumor necrosis factor-alpha overexpression in lung disease. American journal of respiratory and critical care medicine, 171 (12), 1363–1370.
  • Mcdonough, J.E. , et al. , 2011. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. New England journal of medicine, 365 (17), 1567–1575.
  • Mejia, M. , et al. , 2009. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest, 136, 10–15.
  • Rimington, T.L. , et al. , 2017. Defining the inflammatory signature of human lung explant tissue in the presence and absence of glucocorticoid. F1000Research, 6, 460.
  • Ryerson, C.J. , et al. , 2013. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest, 144 (1), 234–240.
  • Saetta, M. , et al. , 2002. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 165 (10), 1404–1409.
  • Selman, M. , et al. , 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Annals of internal medicine, 134 (2), 136–151.
  • Selman, M. , et al. , 2006. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.[see comment]. American journal of respiratory and critical care medicine, 173 (2), 188–198.
  • Stock, C.J. , et al. , 2013. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax, 68 (5), 436–441.
  • Tasaka, S. , et al. , 2012. Cytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema. Respirology (Carlton, VIC.), 17 (5), 814–820.
  • Traves, S.L. , et al. , 2002. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax, 57 (7), 590–595.
  • White, E.S. , et al. , 2016. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. American journal of respiratory and critical care medicine, 194 (10), 1242–1251.
  • Wohlauer, M. , et al. , 2012. Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Critical care medicine, 40 (9), 2647–2653.
  • Zhao, Y. , et al. , 2012. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema. Chinese medical journal, 125, 3015–3021.
  • Zuo, F. , et al. , 2002. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proceedings national academy sciences of USA, 99 (9), 6292–6297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.